These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 8521382

  • 1. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
    Geradts J, Kratzke RA, Niehans GA, Lincoln CE.
    Cancer Res; 1995 Dec 15; 55(24):6006-11. PubMed ID: 8521382
    [Abstract] [Full Text] [Related]

  • 2. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
    Sartor M, Steingrimsdottir H, Elamin F, Gäken J, Warnakulasuriya S, Partridge M, Thakker N, Johnson NW, Tavassoli M.
    Br J Cancer; 1999 Apr 15; 80(1-2):79-86. PubMed ID: 10389982
    [Abstract] [Full Text] [Related]

  • 3. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
    Geradts J, Fong KM, Zimmerman PV, Maynard R, Minna JD.
    Clin Cancer Res; 1999 Apr 15; 5(4):791-800. PubMed ID: 10213214
    [Abstract] [Full Text] [Related]

  • 4. Increased p16 levels correlate with pRb alterations in human urothelial cells.
    Yeager T, Stadler W, Belair C, Puthenveettil J, Olopade O, Reznikoff C.
    Cancer Res; 1995 Feb 01; 55(3):493-7. PubMed ID: 7834615
    [Abstract] [Full Text] [Related]

  • 5. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
    Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN.
    Cancer Res; 1996 Jan 01; 56(1):150-3. PubMed ID: 8548755
    [Abstract] [Full Text] [Related]

  • 6. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast.
    Geradts J, Ingram CD.
    Mod Pathol; 2000 Sep 01; 13(9):945-53. PubMed ID: 11007034
    [Abstract] [Full Text] [Related]

  • 7. Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity.
    Kinoshita I, Dosaka-Akita H, Mishina T, Akie K, Nishi M, Hiroumi H, Hommura F, Kawakami Y.
    Cancer Res; 1996 Dec 15; 56(24):5557-62. PubMed ID: 8971152
    [Abstract] [Full Text] [Related]

  • 8. Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas.
    Huang L, Goodrow TL, Zhang SY, Klein-Szanto AJ, Chang H, Ruggeri BA.
    Cancer Res; 1996 Mar 01; 56(5):1137-41. PubMed ID: 8640773
    [Abstract] [Full Text] [Related]

  • 9. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
    Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA.
    Cancer Res; 1995 Oct 15; 55(20):4531-5. PubMed ID: 7553622
    [Abstract] [Full Text] [Related]

  • 10. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
    Shintani S, Mihara M, Nakahara Y, Kiyota A, Yoshihama Y, Ueyama Y, Matsumura T.
    Anticancer Res; 2000 Oct 15; 20(3B):2169-75. PubMed ID: 10928172
    [Abstract] [Full Text] [Related]

  • 11. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
    Okami K, Reed AL, Cairns P, Koch WM, Westra WH, Wehage S, Jen J, Sidransky D.
    Oncogene; 1999 Jun 10; 18(23):3541-5. PubMed ID: 10376532
    [Abstract] [Full Text] [Related]

  • 12. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R, Shiohara M, Koeffler HP, Fagin JA.
    Cancer; 1998 Nov 15; 83(10):2185-93. PubMed ID: 9827724
    [Abstract] [Full Text] [Related]

  • 13. Aberrant expression of cell-cycle regulatory proteins in human mesenchymal neoplasia.
    Creager AJ, Cohen JA, Geradts J.
    Cancer Detect Prev; 2001 Nov 15; 25(2):123-31. PubMed ID: 11341347
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression.
    Reed JA, Loganzo F, Shea CR, Walker GJ, Flores JF, Glendening JM, Bogdany JK, Shiel MJ, Haluska FG, Fountain JW.
    Cancer Res; 1995 Jul 01; 55(13):2713-8. PubMed ID: 7796391
    [Abstract] [Full Text] [Related]

  • 16. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells.
    Jarrard DF, Sarkar S, Shi Y, Yeager TR, Magrane G, Kinoshita H, Nassif N, Meisner L, Newton MA, Waldman FM, Reznikoff CA.
    Cancer Res; 1999 Jun 15; 59(12):2957-64. PubMed ID: 10383161
    [Abstract] [Full Text] [Related]

  • 17. Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas.
    Lai S, El-Naggar AK.
    Lab Invest; 1999 Mar 15; 79(3):255-60. PubMed ID: 10092061
    [Abstract] [Full Text] [Related]

  • 18. Rb and p16INK4a expression in resected non-small cell lung tumors.
    Kratzke RA, Greatens TM, Rubins JB, Maddaus MA, Niewoehner DE, Niehans GA, Geradts J.
    Cancer Res; 1996 Aug 01; 56(15):3415-20. PubMed ID: 8758904
    [Abstract] [Full Text] [Related]

  • 19. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
    Dreyling MH, Bullinger L, Ott G, Stilgenbauer S, Müller-Hermelink HK, Bentz M, Hiddemann W, Döhner H.
    Cancer Res; 1997 Oct 15; 57(20):4608-14. PubMed ID: 9377576
    [Abstract] [Full Text] [Related]

  • 20. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
    Zariwala M, Xiong Y.
    Oncogene; 1996 Nov 07; 13(9):2033-8. PubMed ID: 8934552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.